News from the FDA/CDC
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
News from the FDA/CDC
New at-home test approved for chlamydia and gonorrhea
“This authorization marks an important public health milestone, giving patients more information about their health from the privacy of their own...
News from the FDA/CDC
CDC says child vaccination exemptions hit all-time high
The overall national vaccination rate remained steady at 93% for children entering kindergarten for the 2022-2023 school year.
News from the FDA/CDC
U.S. infant mortality rates rise for first time in 2 decades
“We live in a country with significant resources, so the infant mortality rate and the increase are shockingly high.”
News
Test all perinatally exposed infants for HCV: CDC
The CDC noted that rates of HCV infections during pregnancy are on the rise.
News from the FDA/CDC
High school students using less tobacco, vape products, CDC report shows
“Sustained efforts to prevent initiation of tobacco product use among young persons and strategies to help young tobacco users quit are critical...
News from the FDA/CDC
FDA to health care providers: Double-check COVID vaccine dose for children
“Parents were telling us of cases where pharmacies accidentally gave their children a double dose, while doctors in our group were pointing out...
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News from the FDA/CDC
New meningococcal vaccine wins FDA approval
The vaccine “has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest...
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...